Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.44 - $6.87 $1.04 Million - $2.08 Million
302,560 New
302,560 $2.08 Million
Q4 2018

Feb 13, 2019

SELL
$16.0 - $31.84 $359,664 - $715,731
-22,479 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$24.32 - $37.54 $546,689 - $843,861
22,479 New
22,479 $721,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $49.7M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.